KBC

KBC

Signal active

Investment Firm

Overview

KBC Private Equity - the investment company of KBC Group - provides development capital and finances buy-outs to medium-sized companies in Belgium and in Central and Eastern Europe, KBC's home markets. Boasting an experienced team of 28 people, it has more than 60 active investments in portfolio with a market value in excess of EUR 400 million.

KBC Private Equity aims to become one of the leading private equity providers on KBC Group's home markets. As an active shareholder with a long-term perspective, KBC Private Equity is involved in taking strategic decisions and providing support to management teams.

Highlights

Founded

1935

Industry

Banking

Employees

10001+

Investment

25

Lead Investment

8

Exits

9

Stages

Early Stage Venture, Late Stage Venture, Seed

Investor Type

Investment Bank

Location

Europe

Contact Information

Social

Profile Resume

KBC, established in 1935 and headquartered in Europe., specializes in Early Stage Venture, Late Stage Venture, Seed investments across Music, Customer Service, Biotechnology, Life Science, CleanTech, Therapeutics, Clinical Trials, Financial Services, Venture Capital, Health Care. The organization boasts a portfolio of 26 investments, with an average round size of $35.4M and 9 successful exits. Their recent investments include Aristo Music Technology, Limburgse Reconversie Maatschappij, argenx, BioGeneration Ventures, Forbion Capital Partners. The highest investment round they participated in was $105.6B. Among their most notable exits are Aristo Music Technology and Limburgse Reconversie Maatschappij. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Remi Vermeiren

Remi Vermeiren

Chief Executive Officer and President

imagePlace Gerd Smeets

Gerd Smeets

Investment Director

imagePlace Daniel Vercauteren

Daniel Vercauteren

Investment Director

imagePlace Thomas Leysen

Thomas Leysen

Chairman of the Board

imagePlace Philippe Vlerick

Philippe Vlerick

Deputy Chairman of Board

imagePlace Johan Thijs

Johan Thijs

CEO KBC Group

Investment portfolio

KBC has made 25 investments. Their most recent investment was on Mar 14, 2024, when ELIS raised $435.3M.

investments

25

Diversity investments

0

Lead investments

8

Number of exits

9

Investments

25

Annouced DateOrganization NameIndustryMoney Raised
Dec 15, 2021
Allegro Biotech Allegro Biotech
Biotechnology1.7M
May 24, 2022
Unbox Unbox
Web38.0M
Mar 12, 2024
MICLEDI Microdisplays MICLEDI Microdisplays
Semiconductor25.0M
Mar 14, 2024
ELIS ELIS
Service Industry435.3M

Exits

9

Funding Timeline

Funding rounds

25

Investors

0

Funds

0

Funding Rounds

25

KBC has raised 25 rounds. Their latest funding was raised on Mar 14, 2024 from a Post-IPO Debt - ELIS round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Dec 15, 2021
Pre Seed Round - Allegro Biotech Pre Seed Round - Allegro Biotech
-1.7M-
May 24, 2022
Seed Round - Unbox Seed Round - Unbox
-8.0M-
Mar 12, 2024
Series A - MICLEDI Microdisplays Series A - MICLEDI Microdisplays
-25.0M-
Mar 14, 2024
Post-IPO Debt - ELIS Post-IPO Debt - ELIS
-435.3M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.